{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:40:56Z","timestamp":1792590056898,"version":"4.5.0"},"reference-count":29,"publisher":"MyJove Corporation","issue":"230","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/70413","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T23:04:16Z","timestamp":1777158256000},"source":"Crossref","is-referenced-by-count":0,"title":["Enhancement of Intestinal Recombinant Adeno-Associated Virus Absorption by a Traditional Chinese Medicine Formula"],"prefix":"10.3791","author":[{"given":"Enze","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huawei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxiao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huida","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changquan","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","type":"journal-article","article-title":"Adeno-associated virus as a delivery vector for gene therapy of human diseases","volume":"9","author":"Wang","year":"2024","unstructured":"Wang, J. H. et al. Adeno-associated virus as a delivery vector for gene therapy of human diseases. Signal Transduct Target Ther. 9 (1), 78 (2024).","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"102569","DOI":"10.1016\/j.omtn.2025.102569","type":"journal-article","article-title":"Optimized genomic editing of a common Duchenne muscular dystrophy mutation in patient-derived muscle cells and a new humanized mouse model","volume":"36","author":"Durbacz","year":"2025","unstructured":"Durbacz, M. Z. et al. Optimized genomic editing of a common Duchenne muscular dystrophy mutation in patient-derived muscle cells and a new humanized mouse model. Mol Ther Nucleic Acids. 36 (2), 102569 (2025).","journal-title":"Mol Ther Nucleic Acids"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3233\/JAD-160514","type":"journal-article","article-title":"An oral A\u03b2 vaccine using a recombinant adeno-associated virus vector in aged monkeys: reduction in plaque amyloid and increase in A\u03b2 oligomers","volume":"54","author":"Hara","year":"2016","unstructured":"Hara, H. et al. An oral A\u03b2 vaccine using a recombinant adeno-associated virus vector in aged monkeys: reduction in plaque amyloid and increase in A\u03b2 oligomers. J Alzheimers Dis. 54 (3), 1047-1059 (2016).","journal-title":"J Alzheimers Dis"},{"issue":"13","key":"ref4","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1089\/10430340260201662","type":"journal-article","article-title":"Oral administration of recombinant adeno-associated virus elicits human immunodeficiency virus-specific immune responses","volume":"13","author":"Xin","year":"2002","unstructured":"Xin, K. Q. et al. Oral administration of recombinant adeno-associated virus elicits human immunodeficiency virus-specific immune responses. Hum Gene Ther. 13 (13), 1571-1581 (2002).","journal-title":"Hum Gene Ther"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3233\/JAD-2004-6504","type":"journal-article","article-title":"Development of a safe oral Abeta vaccine using recombinant adeno-associated virus vector for Alzheimer's disease","volume":"6","author":"Hara","year":"2004","unstructured":"Hara, H. et al. Development of a safe oral Abeta vaccine using recombinant adeno-associated virus vector for Alzheimer's disease. J Alzheimers Dis. 6 (5), 483-488 (2004).","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/mt.2012.260","type":"journal-article","article-title":"Oral vaccination with adeno-associated virus vectors expressing the neu oncogene inhibits the growth of murine breast cancer","volume":"21","author":"Steel","year":"2013","unstructured":"Steel, J. C. et al. Oral vaccination with adeno-associated virus vectors expressing the neu oncogene inhibits the growth of murine breast cancer. Mol Ther. 21 (3), 680-687 (2013).","journal-title":"Mol Ther"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1002\/hep.20918","type":"journal-article","article-title":"Oral adeno-associated virus-sTRAIL gene therapy suppresses human hepatocellular carcinoma growth in mice","volume":"42","author":"Ma","year":"2005","unstructured":"Ma, H. et al. Oral adeno-associated virus-sTRAIL gene therapy suppresses human hepatocellular carcinoma growth in mice. Hepatology. 42 (6), 1355-1363 (2005).","journal-title":"Hepatology"},{"issue":"11","key":"ref8","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1038\/mt.2012.148","type":"journal-article","article-title":"Oral administration of recombinant adeno-associated virus-mediated bone morphogenetic protein-7 suppresses CCl4-induced hepatic fibrosis in mice","volume":"20","author":"Hao","year":"2012","unstructured":"Hao, Z. M. et al. Oral administration of recombinant adeno-associated virus-mediated bone morphogenetic protein-7 suppresses CCl4-induced hepatic fibrosis in mice. Mol Ther. 20 (11), 2043-2051 (2012).","journal-title":"Mol Ther"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/mt.2016.34","type":"journal-article","article-title":"Genetic manipulation of brown fat via oral administration of an engineered recombinant adeno-associated viral serotype vector","volume":"24","author":"Huang","year":"2016","unstructured":"Huang, W. et al. Genetic manipulation of brown fat via oral administration of an engineered recombinant adeno-associated viral serotype vector. Mol Ther. 24 (6), 1062-1069 (2016).","journal-title":"Mol Ther"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/mtm.2013.8","type":"journal-article","article-title":"Adipose tissue insulin receptor knockdown via a new primate-derived hybrid recombinant AAV serotype","volume":"1","author":"Liu","year":"2014","unstructured":"Liu, X. et al. Adipose tissue insulin receptor knockdown via a new primate-derived hybrid recombinant AAV serotype. Mol Ther Methods Clin Dev. 1, 8 (2014).","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.2042-7158.2011.01391.x","type":"journal-article","article-title":"Everted gut sac model as a tool in pharmaceutical research: limitations and applications","volume":"64","author":"Alam","year":"2012","unstructured":"Alam, M. A., Al-Jenoobi, F. I., Al-Mohizea, A. M. Everted gut sac model as a tool in pharmaceutical research: limitations and applications. J Pharm Pharmacol. 64 (3), 326-336 (2012).","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.18433\/J3GC7R","type":"journal-article","article-title":"Comparative study of two in vitro methods for assessing drug absorption: Sartorius SM 16750 apparatus versus everted gut sac","volume":"14","author":"Lassoued","year":"2011","unstructured":"Lassoued, M. A., Khemiss, F., Sfar, S. Comparative study of two in vitro methods for assessing drug absorption: Sartorius SM 16750 apparatus versus everted gut sac. J Pharm Pharm Sci. 14 (1), 117-127 (2011).","journal-title":"J Pharm Pharm Sci"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.joim.2024.06.001","type":"journal-article","article-title":"From ancient wisdom to modern science: Gut microbiota sheds light on property theory of traditional Chinese medicine","volume":"22","author":"Yang","year":"2024","unstructured":"Yang, Y.-N., Zhan, J.-G., Cao, Y., Wu, C.-M. From ancient wisdom to modern science: Gut microbiota sheds light on property theory of traditional Chinese medicine. J. Integr. Med. 22 (4), 413-444 (2024).","journal-title":"J. Integr. Med"},{"issue":"2","key":"ref14","first-page":"509","type":"journal-article","article-title":"Intestinal absorption components and absorption characteristics of Wuwei Qingzhuo San by everted intestinal sac models","volume":"49","author":"Liao","year":"2024","unstructured":"Liao, C. P. et al. Intestinal absorption components and absorption characteristics of Wuwei Qingzhuo San by everted intestinal sac models. Zhongguo Zhong Yao Za Zhi. 49 (2), 509-517 (2024).","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"9","key":"ref15","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/ptr.5148","type":"journal-article","article-title":"Transport properties of puerarin and effect of extract of Radix Angelicae Dahuricae on puerarin intestinal absorption using in situ and in vitro models","volume":"28","author":"Liao","year":"2014","unstructured":"Liao, Z. G. et al. Transport properties of puerarin and effect of extract of Radix Angelicae Dahuricae on puerarin intestinal absorption using in situ and in vitro models. Phytother Res. 28 (9), 1288-1294 (2014).","journal-title":"Phytother Res"},{"issue":"10","key":"ref16","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/2625","type":"journal-article","article-title":"Peroral gene therapy of lactose intolerance using an adeno-associated virus vector","volume":"4","author":"During","year":"1998","unstructured":"During, M.J., Xu, R., Young, D., Kaplitt, M.G., Sherwin, R.S., Leone, P. Peroral gene therapy of lactose intolerance using an adeno-associated virus vector. Nat. Med. 4 (10), 1131-1135 (1998).","journal-title":"Nat. Med"},{"issue":"7","key":"ref17","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/jgm.2642","type":"journal-article","article-title":"Intracolonically administered adeno-associated virus-bone morphogenetic protein-7 ameliorates dextran sulphate sodium-induced acute colitis in rats","volume":"14","author":"Hao","year":"2012","unstructured":"Hao, Z., Yang, X., Lv, Y., Li, S., Purbey, B.K., Su, H. Intracolonically administered adeno-associated virus-bone morphogenetic protein-7 ameliorates dextran sulphate sodium-induced acute colitis in rats. J. Gene Med. 14 (7), 482-490 (2012).","journal-title":"J. Gene Med"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.joim.2024.01.001","type":"journal-article","article-title":"Melittin analog p5RHH enhances recombinant adeno-associated virus transduction efficiency","volume":"22","author":"Meng","year":"2024","unstructured":"Meng, J.-S. et al. Melittin analog p5RHH enhances recombinant adeno-associated virus transduction efficiency. J. Integr. Med. 22 (1), 72-82 (2024).","journal-title":"J. Integr. Med"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1517\/17425255.4.4.395","type":"journal-article","article-title":"The Caco-2 cell monolayer: usefulness and limitations","volume":"4","author":"Sun","year":"2008","unstructured":"Sun, H. et al. The Caco-2 cell monolayer: usefulness and limitations. Expert Opin Drug Metab Toxicol. 4 (4), 395-411 (2008).","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/vetsci3040031","type":"journal-article","article-title":"Intestinal organoids\u2014current and future applications","volume":"3","author":"Meneses","year":"2016","unstructured":"Meneses, A. M. C. et al. Intestinal organoids\u2014current and future applications. Vet Sci. 3 (4), 31 (2016).","journal-title":"Vet Sci"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12876-019-1002-4","type":"journal-article","article-title":"The Ussing chamber system for measuring intestinal permeability in health and disease","volume":"19","author":"Thomson","year":"2019","unstructured":"Thomson, A. et al. The Ussing chamber system for measuring intestinal permeability in health and disease. BMC Gastroenterol. 19 (1), 98 (2019).","journal-title":"BMC Gastroenterol"},{"issue":"1-2","key":"ref22","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijpharm.2018.09.022","type":"journal-article","article-title":"Determination of intestinal permeability using in situ perfusion model in rats: challenges and advantages to BCS classification applied to digoxin","volume":"551","author":"Caldeira","year":"2018","unstructured":"Caldeira, T. G. et al. Determination of intestinal permeability using in situ perfusion model in rats: challenges and advantages to BCS classification applied to digoxin. Int J Pharm. 551 (1-2), 148-157 (2018).","journal-title":"Int J Pharm"},{"issue":"8","key":"ref23","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3390\/pharmaceutics11080411","type":"journal-article","article-title":"Intestinal permeability and drug absorption: predictive experimental, computational and in vivo approaches","volume":"11","author":"Dahlgren","year":"2019","unstructured":"Dahlgren, D., Lennern\u00e4s, H. Intestinal permeability and drug absorption: predictive experimental, computational and in vivo approaches. Pharmaceutics. 11 (8), 411 (2019).","journal-title":"Pharmaceutics"},{"issue":"108","key":"ref24","first-page":"e53250","type":"journal-article","article-title":"Ex vivo intestinal sacs to assess mucosal permeability in models of gastrointestinal disease","author":"Mateer","year":"2016","unstructured":"Mateer, S. W. et al. Ex vivo intestinal sacs to assess mucosal permeability in models of gastrointestinal disease. J Vis Exp. (108), e53250 (2016).","journal-title":"J Vis Exp"},{"issue":"7","key":"ref25","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3390\/ijms17071171","type":"journal-article","article-title":"Developments in methods for measuring the intestinal absorption of nanoparticle-bound drugs","volume":"17","author":"Liu","year":"2016","unstructured":"Liu, W. et al. Developments in methods for measuring the intestinal absorption of nanoparticle-bound drugs. Int J Mol Sci. 17 (7), 1171 (2016).","journal-title":"Int J Mol Sci"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"27923","DOI":"10.1038\/s41598-024-79369-0","type":"journal-article","article-title":"Crucial aspects for maintaining rAAV stability","volume":"14","author":"Lengler","year":"2024","unstructured":"Lengler, J. et al. Crucial aspects for maintaining rAAV stability. Sci Rep. 14, 27923. (2024).","journal-title":"Sci Rep"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/mt.2015.7","type":"journal-article","article-title":"Targeted gene delivery to the enteric nervous system using AAV: a comparison across serotypes and capsid mutants","volume":"23","author":"Benskey","year":"2015","unstructured":"Benskey, M. J. et al. Targeted gene delivery to the enteric nervous system using AAV: a comparison across serotypes and capsid mutants. Mol Ther. 23 (3), 488-500 (2015).","journal-title":"Mol Ther"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s10620-007-9991-1","type":"journal-article","article-title":"Gene delivery to intestinal epithelial cells in vitro and in vivo with recombinant adeno-associated virus types 1, 2, and 5","volume":"53","author":"Polyak","year":"2008","unstructured":"Polyak, S. et al. Gene delivery to intestinal epithelial cells in vitro and in vivo with recombinant adeno-associated virus types 1, 2, and 5. Dig Dis Sci. 53 (5), 1261-1270 (2008).","journal-title":"Dig Dis Sci"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"637953","DOI":"10.1100\/2012\/637953","type":"journal-article","article-title":"A comprehensive review on pharmacotherapeutics of herbal bioenhancers","volume":"2012","author":"Dudhatra","year":"2012","unstructured":"Dudhatra, G. B. et al. A comprehensive review on pharmacotherapeutics of herbal bioenhancers. Scientific World Journal. 2012, 637953 (2012).","journal-title":"Scientific World Journal"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jove.com\/t\/70413\/enhancement-intestinal-recombinant-adeno-associated-virus-absorption","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:55:35Z","timestamp":1792587335000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/70413\/enhancement-intestinal-recombinant-adeno-associated-virus-absorption"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":29,"journal-issue":{"issue":"230","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3791\/70413","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]}}}